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Letter

A p38α-Selective Chemosensor for use in
Unfractionated Cell Lysates
Cliff I. Stains, Elvedin Luković, and Barbara Imperiali
Departments of Chemistry and Biology, Massachusetts Institute of Technology,
77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA

M

ethods for assessing kinase activities have relied
on the transfer of a radioactive γ-phosphoryl moiety from ATP
to substrate and have been very useful for in vitro studies of kinases. However, beyond being discontinuous,
this assay is incompatible with unfractionated cell lysates since ATP is a
common substrate for most kinases.
This has prompted the development
of protein-based fluorescence resonance energy transfer (FRET) sensors for probing kinase activity (1-3).
While useful, these FRET-based sensors produce modest changes in fluorescence upon phosphorylation. Alternatively, the development of methods
based on small organic fluorophores
has provided sensitive probes for interrogating biological functions (4, 5). Recently our laboratory has introduced a
direct kinase assay strategy based on
chelation-enhanced fluorescence of a
cysteine derivative of a sulfonamidooxine fluorophore (6), which we term
CSox (Figure 1, panel a). Placed (−)2
or (+)2 relative to the phosphorylation
site in an optimized kinase substrate,
the CSox amino acid provides a readily observable increase in fluorescence
signal in response to phosphorylation
due to chelation of Mg2+ between the
newly installed phosphoryl group and
CSox. These probes afford sensitive
real-time fluorescence readouts of kinase activity in unfractionated cell lysates (7, 8), provided that selective
substrate sequences for the kinase of
interest can be identified (5, 9, 10).
Recently p38α, a member of the
mitogen-activated protein kinase

(MAPK) family, has been the target
of a variety of drug development efforts (11, 12) since inhibitors of this kinase may provide treatments for inflammatory diseases (13). Additionally,
increased activation of p38α in tumor
tissue derived from patients with nonsmall cell lung carcinoma has been
observed (14, 15). Consequently, with
the goal of developing a direct p38α
chemosensor that would be compatible with unfractionated cell lysates, we
investigated strategies for generating
selective substrates for MAPKs.
In the case of MAPKs the development of selective probes has proved
more challenging due to the minimal
local consensus phosphorylation sequence, S/T-P. This class of enzymes
(including the ERK, JNK, and p38
family members) derives specificity
through the use of extended protein or
peptide docking domains that are distal to the phosphorylation site (16, 17).
These docking domains serve to target a substrate to a particular kinase
and can therefore be viewed as unique
address elements. Due to the limited
structural information concerning p38α
substrates, we chose to employ a strategy in which a known docking peptide sequence (18, 19) (Figure 1, panel
b) would be linked to a CSox-based
phosphorylation site via a flexible linker
(16) (Figure 1, panel c). Initial phosphorylation reactions indicated that this
sensor, MEF2A-CSox, could act as a
substrate for purified p38α (Supplementary Figure S1). Phosphorylation
reactions containing differing amounts
of MEF2A-CSox demonstrated a KM
and Vmax for p38α of 1.3 μM and 1.1
μmol mg−1 min−1, respectively
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(Figure 2, panel a). We then assessed
the specificity of MEF2A-CSox by exposing it to a panel of related kinases
(Figure 2, panel b). MEF2A-CSox was
selectively phosphorylated by p38α
and showed minimal background activity in the presence of the closely related p38β isoform (8%) and the remaining kinase panel. Importantly,
this difference in selectivity for p38α
over p38β translated into a 17-fold enhancement in catalytic efficiency for
p38α (Supplementary Figure S2). Encouraged by these in vitro studies,
we investigated the ability of MEF2ACSox to report p38α activation in unfractionated cell lysates.
Several studies have demonstrated
p38α activation in response to inflammatory cytokines or cellular stress
(20). With this in mind, we treated
HeLa cells with increasing amounts
of the cytokine TNFα (Supplementary
Figure S3). These initial experiments
demonstrated that MEF2A-CSox was
capable of reporting p38α activation despite appreciable signal due to
phosphorylation by off-target kinases.
A recent survey of kinase inhibitors
(21) indicated that the broad spectrum
inhibitor staurosporine is not effective
against p38α, which was confirmed
using recombinant enzyme (Supplementary Figure S4). Consequently we
hypothesized that, in this case, staurosporine may be used to reduce the
off-target kinase activities allowing for
discrimination of the p38α signal. Indeed, the addition of 1 μM staurosporine to assays using sorbitol-stimulated
lysates demonstrated that a portion of
off-target kinases could be suppressed
by using this promiscuous inhibitor
(Figure 3, panel a), and therefore staurosporine was added to all subsequent
lysate assays. A comparison between
TNFα and sorbitol stimulation indicated an increase of 68% in the rate of
MEF2A-CSox phosphorylation in cells
stimulated by osmotic shock (Figure
3, panel b), and consequently these
lysates were used to optimize assay
conditions. Optimal signal-to-noise
for sorbitol-stimulated lysates was obtained using 10 μg of total protein
(Supplementary Figure S5), which provided a clearly discernible enhancement in the rate of phosphorylation of
MEF2A-CSox (Figure 3, panel c). Using small molecule inhibitors of p38α,
specifically SB203580, which is
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Figure 1. Rational design of a p38α chemosensor. a) A schematic of the chelation-enhanced fluorescence of the CSox amino acid upon phosphorylation. b) Crystal structure
of the MEF2A docking peptide bound to p38α (left) and distances in Å from the C-terminus of the docking peptide to representative distal regions of the catalytic and substratebinding domains of the kinase (right) (18). c) Amino acid sequence of the MEF2A-CSox
sensor with the position of CSox (blue) and the site of phosphorylation (red) indicated.
The flexible 8-amino-3,6-dioxaoctanoic acid (AOO) linker is also shown.

Figure 2. MEF2A-CSox is a substrate for recombinant p38α. a) Direct fit of a velocity versus MEF2A-CSox concentration plot using the Briggs−Haldane equation. b) Phosphorylation reactions were conducted with the indicated recombinant kinase (15 nM) using 1
μM substrate and demonstrate that MEF2A-CSox is selective for p38α among these kinases. The inset shows the average reaction slope for each kinase.

ATP competitive (22-24), and
BIRB796, a slow-binding allosteric inhibitor (25), the origin of the increase
in the rate of MEF2A-CSox phosphorylation upon osmotic shock was investigated. The addition of 1 μM of each
of these compounds, which completely
abolishes activity of recombinant
kinase (Supplementary Figure S6),
reduced the rate of phosphorylation of
MEF2A-CSox in sorbitol-stimulated

HeLa lysates to levels observed for serum starved cells (Figure 3, panel d).
Appropriate control measurements established that this effect was not due
to the inhibitor solvent (DMSO) (Supplementary Figure S7).
We sought to further verify the selectivity of MEF2A-CSox for p38α
through a series of inhibition studies,
immunodepletion experiments, and
analyses across different cell lines
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Figure 3. Reducing off-target phosphorylation of MEF2A-CSox in unfractionated cell lysates. a) Reactions were conducted using 1 μM substrate and 10 μg of the indicated
HeLa lysate with or without the addition of staurosporine. The inset shows a Western blot
analysis of the indicated lysates, demonstrating p38 activation upon stimulation. b) Relative reaction slopes obtained using 1 μM substrate and 5 μg of the indicated lysates. The
inset shows a Western blot analysis of each lysate. c) Initial phosphorylation reactions
using 10 μg of total cellular protein from the indicated HeLa cell lysate demonstrated
that MEF2A-CSox (1 μM) could report on the presence of active p38. Data is corrected
for lag times. d) Assays were performed using lysates from serum-starved or stimulated
cells (10 μg) with MEF2A-CSox (1 μM). Inhibitors of p38α were added to the reactions
containing lysates from stimulated cells where indicated. All reactions contained 1 μM
staurosporine unless otherwise noted.

Accordingly, the phosphorylation of
MEF2A-CSox was determined in the
presence of varying concentrations
of SB203580 and BIRB796 (Figure 4,
panels a and b, respectively). A concentration-dependent decrease in the
rate of phosphorylation of MEF2ACSox was observed in the presence
of SB203580, yielding a Ki of 7.5 nM,
which reflects the reported Ki of 21
nM (24). A similar dose-dependent response was observed for BIRB796
that was in good correlation with previously reported values (25). Importantly, these experiments indicate that
the remaining background activity due
to off-target kinases could be essentially eliminated through background
subtraction of parallel reactions

containing 1 μM SB203580 (see also
Figure 3, panel d). Accordingly, to further verify the specificity of MEF2ACSox, p38α immunodepletion studies
were performed in which the activity remaining after the addition of
SB203580 was used for background
subtraction. These depletions clearly
demonstrate that the increase in the
rate of phosphorylation of MEF2ACSox upon stimulation by osmotic
shock is predominantly due to p38α
(Figure 4, panel c). Moreover, similar
depletions for the related kinase ERK5
(26) demonstrated no appreciable loss
of signal (Supplementary Figure S8).
In combination with the known selectivity profiles for the inhibitors used
herein (21) (Supplementary Table S1),
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these results indicate that MEF2ACSox is a p38α-selective activity probe
and that off-target signal can be virtually eliminated using SB203580.
Finally, we investigated the ability of MEF2A-CSox to report the activation of p38α in a variety of cell lines
isolated from different tissues and species. Indeed MEF2A-CSox was capable of reporting the activation of p38α
in HeLa (human), Cos7 (simian), and
NIH-3T3 (rodent) cells (Figure 4, panel
d). The activity in each lysate correlated with Western blot analyses indicating that MEF2A-CSox can be used
in a variety of mammalian systems
and tissues to directly interrogate p38α
activity levels.
We have designed and validated
the first isoform-selective p38 activity probe compatible with unfractionated cell lysates. This probe provides
isoform-specific activity information
that cannot be obtained through the
use of currently available phosphospecific antibodies. Because the synthesis described herein produces 2.4 mg
of MEF2A-CSox, sufficient material for
7,000 assays in 96-well plate format or
28,000 assays in 384-well format (7),
this sensor could easily be utilized to
rapidly screen compound libraries to
identify p38α inhibitors. Furthermore,
we envision that this sensor will be
useful for detailing the changes in kinase signaling pathways during cellular transformations such as differentiation and cancer development (15).
Methods
General Reagents and Methods. Low
metals grade chemicals were obtained from
Sigma and Alfa Aesar. Lysates were normalized for total protein content using the
Bio-Rad protein assay (500−0006) with
BSA as a standard. Fluorescence emission was acquired at 485 nm using 360 nm
excitation on either a HTS 7000 Bio Assay Reader (Perkin-Elmer) or Spectramax
Gemini XS (Molecular Devices, 455 nm
cutoff) plate reader. All fluorescence assays
were performed at 30 °C in 96-well plates
(Corning, 3992).
Synthesis of MEF2A-Csox. MEF2ACSox was synthesized using standard
Fmoc-based solid-phase peptide synthesis methods as described previously (6).
The linker in MEF2A-CSox was installed by
coupling three Fmoc-protected AOO linkers (Novabiochem, 851037) to the growing
peptide chain on 100 mg of PAL-PEG-PS
resin (0.19 mmol g−1 substitution, Applied
Biosystems). The Sox fluorophore was
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Figure 4. MEF2A-CSox can selectively report on p38α activation in unfractionated cell lysates. Dose-dependent responses to the addition of SB203580 (a) and BIRB796 (b) were
observed in sorbitol-stimulated lysates (10 μg) using MEF2A-CSox (1 μM). The observed
IC50 and structure of each compound are shown in the inset. c) Phosphorylation reactions
were performed on lysates that had been depleted using a p38α-specific antibody. Values were background subtracted using the activity remaining in the input lysate after addition of 1 μM SB203580. The inset shows a Western blot of the immunodepleted lysates.
d) The indicated cell lines were stimulated with 300 mM sorbitol for 1 h (S). Phosphorylation reactions were performed as above and compared to lysates from cells that had not
been stimulated (C). The amount of p38α activity in each individual lysate was determined
by subtracting the activity remaining after the addition of 1 μM SB203580. Western blots
for both total and active p38 are shown above each sample. All reactions contained 1 μM
staurosporine.
incorporated via on-resin alkylation of a selectively deprotected cysteine residue (6).
The resulting peptide was acetyl-capped at
the N-terminus and included a C-terminal
amide derived from the resin. Purification
was carried out by standard reverse phase
HPLC. Characterization was performed using ESI-MS, and concentrations were determined based on the Sox chromophore
using the absorbance of the peptide at
355 nm in 0.1 M NaOH containing 1 mM
Na2EDTA (extinction coefficient = 8,427 M−1
cm−1) (27).
MEF2A-CSox Reactions Containing
Recombinant Enzyme. Reactions were
carried out using 15 nM of the indicated enzyme (Invitrogen) and 1 μM MEF2A-CSox
in a buffer containing 50 mM Tris-HCl (pH =
7.5 at 25 °C), 10 mM MgCl2, 1 mM EGTA,

2 mM DTT, 0.01% Triton X-100, and 1 mM
ATP in a final volume of 120 μL. Well-towell path length variation was corrected by
normalizing to starting intensities.
Determination of Kinetic Parameters
of MEF2A-CSox with p38α and β. Reactions were performed as above using 1 ng
of recombinant human p38α or β (Invitrogen) with increasing concentrations of substrate. Initial reaction slopes were then converted to rates as described previously
(27).
Recombinant Kinase Panel Assays.
Reactions were conducted as described
above with 1 μM MEF2A-CSox and 15 nM
of the indicated kinase (Invitrogen).
Preparation of Cell Lysates. HeLa
cells were propagated in 90% DMEM supplemented with 10% heat-inactivated FBS,
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50 U mL−1 penicillin, and 50 μg mL−1 streptomycin. Cos7 and NIH-3T3 cells were
propagated in 90% DMEM supplemented
with 10% FBS, 50 U mL−1 penicillin, and
50 μg mL−1 streptomycin. Prior to stimulation, cells were starved overnight (14 h) by
the addition of DMEM supplemented with 2
mM l-Gln, 50 U mL−1 penicillin, and 50 μg
mL−1 streptomycin. Cells were stimulated
by the addition of the indicated amount of
TNFα (Cell Signaling) for 10 min or sorbitol
to 300 mM for 1 h. Cells were then washed
with ice-cold PBS and lysed on ice in 50
mM Tris (pH = 7.5 at 25 °C), 150 mM NaCl,
50 mM β-glycerophosphate, 10 mM sodium
pyrophosphate, 30 mM NaF, 1% Triton
X-100, 2 mM EGTA, 100 μM Na3VO4, 1 mM
DTT, protease inhibitor cocktail III (10 μL
mL−1, Calbiochem, 539134), and phosphatase inhibitor cocktail 1 (10 μL mL−1, Sigma,
P2825). Lysates were clarified by centrifugation, and supernatants were flash frozen
in liquid nitrogen and stored at −80 °C.
Immunodepletions. Immunodepletions were conducted as described previously (8). Briefly, sorbitol-stimulated HeLa
lysates were aliquoted into separate samples (350 μg each) at 4 °C. Depletions were
conducted using a rabbit anti-p38α (1 μg)
antibody (Cell Signaling, 9218) along with a
naïve rabbit IgG control (1 μg, GE Life Sciences). Antibody-bound complexes were
precipitated by the addition of Protein A
agarose conjugated beads (GE Life Sciences). Input (untreated) samples were
used to determined the amount of activity
lost due to handling, while a separate sample was treated with Protein A beads alone
to determine the amount of activity lost
due to nonspecific binding to the resin. Lysates were flash frozen and stored at −80
°C. ERK5 depletions were conducted in a
similar manner using the appropriate antibody (Cell Signaling, 3372). The rate of
phosphorylation by off-target kinases was
background-subtracted using the activity remaining after the addition of 1 μM
SB203580 to the input lysates.
MEF2A-CSox Lysate Assays. Assays were typically conducted using 1 μM
MEF2A-CSox, 10 μg of total protein from
cell lysates, and 1 μM staurosporine, unless otherwise indicated. Reactions were
prepared in bulk in a buffer consisting of 50
mM Tris-HCl (pH = 7.5 at 25 °C), 10 mM
MgCl2, 1 mM EGTA, 2 mM DTT, and 0.01%
Brij 35 P with the indicated concentration
of p38α inhibitor and aliquoted into 96-well
plates. After addition of lysate, reactions (final volume 120 μL) were incubated at 30
°C, and fluorescence emission was monitored. Data were corrected for lag times
(typically 5−10 min, after which fluorescence increases were linear with respect to
time for at least 1 h) as well as variations in
well-to-well path lengths. For titrations with
SB203580, the calculated IC50 was converted to a Ki value using the Cheng−Prussof equation with the concentration of ATP
in the assay and the reported KM of p38α
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for ATP (24). Slopes for assays containing the slow-binding inhibitor BIRB796 (25)
were determined after a 10 min incubation
of the entire solution at 30 °C. After this incubation fluorescence increases were linear with respect to time for at least 1 h.
Slopes of phosphorylation reactions for
assays containing lysates from different cell
lines (Figure 4, panel d) were background
corrected using the activity remaining in
each individual lysate after the addition of 1
μM SB203580.
Western Blot Analysis. Lysates (20 μg
total protein unless noted) were separated
by SDS-PAGE, and proteins were transferred to a nitrocellulose membrane. Blots
were probed with primary antibodies for total p38 (Cell Signaling, 9212), phospho-p38
(Cell Signaling, 9215), p38α, p38β (Cell
Signaling, 2339), total ERK5 (Cell Signaling, 3372), or phospho-ERK5 (Cell Signaling, 3371, 300 μg of total protein used for
blot), which were detected using an HRP
conjugated goat anti-rabbit secondary antibody (Pierce, 32460). Blots were visualized
by enhanced chemiluminescence (Pierce,
34075).
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Supplementary Figure S1. MEF2A-CSox is a substrate for p38α. Initial phosphorylation
reactions with and without the addition of kinase (15 nM) indicated that MEF2A-CSox (1 µM)
was a substrate for p38α.

S2

Supplementary Figure S2. Kinetic parameters of MEF2A-CSox for p38β. a) A direct fit of a
velocity versus MEF2A-CSox concentration plot using the Briggs-Haldane equation (1 ng p38β).
b) Kinetic parameters of MEF2A-CSox for the indicated kinases, demonstrating that MEF2ACSox is a more efficient substrate for p38α. Catalytic efficiency was determined using relative
kcat/KM values.

S3

Supplementary Figure S3. MEF2A-CSox phosphorylation varies with TNFα stimulation. a)
Fluorescence slopes of reactions conducted without staurosporine using 1 µM substrate and 5
µg of HeLa lysates derived from cells stimulated for 10 min with the indicated amount of TNFα.
Assays were also performed with lysates from untreated (serum starved) cells. b) The
relationship between MEF2A-CSox phosphorylation and the amount of TNFα used for
stimulation. c) A western blot of the indicated lysates with the corresponding antibodies,
demonstrating increased phosphorylation of p38 with increasing amounts of TNFα.
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Supplementary Figure S4. Staurosporine does not significantly alter p38α activity (1).
Reactions were performed using 1 nM recombinant p38α and 1 µM substrate.
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Supplementary Figure S5. The effect of the amount of lysate used in the assay on the rate of
phosphorylation of MEF2A-CSox. a) Reactions conducted with 1 µM substrate and the indicated
amount of serum starved and sorbitol-stimulated HeLa lysates. b) The fold change in reaction
slope between sorbitol-stimulated and serum starved lysates with respect to the amount of
lysate used in the assay. The assay is most sensitive when 10 µg of lysate is used. Presumably
the sensitivity of the assay decreases with increasing concentrations of lysate due to the
increasing amounts of off-target kinases. All reactions contained 1 µM staurosporine.
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Supplementary Figure S6. The addition of 1 µM SB203580 or BIRB796 completely abolishes
recombinant p38α activity. Reactions were conducted with 1 µM substrate and 1 nM
recombinant enzyme. Slopes for assays containing the slow-binding inhibitor BIRB796 were
determined after incubation of the entire reaction at 30 oC for 30 min prior to data collection,
after which fluorescence increases were linear with respect to time.
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Supplementary Figure S7. The inhibitor solvent, DMSO, does not influence the
phosphorylation of MEF2A-CSox. Assays were conducted using 1 µM MEF2A-CSox and 10 µg
of sorbitol-stimulated HeLa lysates with the indicated inhibitor. All reactions contained 1 µM
staurosporine.
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Supplementary Figure S8. The related ERK5 kinase does not significantly contribute to the
phosphorylation of MEF2A-CSox (1 µM) in sorbitol-stimulated HeLa cell lysates. a) Western blot
analysis of sorbitol-stimulated lysates demonstrating activation of ERK5. b) Immunodepletion of
p38α leads to a dramatic decrease in MEF2A-CSox phosphorylation (left) while depletion of
ERK5 demonstrated no significant loss of signal (right). Values were background subtracted
using the activity remaining in the input lysates after addition of 1 µM SB203580. Western blots
of the respective lysates demonstrating depletion of the target kinase are shown in the insets of
each panel. Note that p38β levels remain unchanged, indicating that the remaining MEF2ACSox activity is likely due to residual p38α (~30% remaining by gel densitometry). All reactions
contained 1 µM staurosporine.
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Supplementary Table S1. Reported dissociation constants of SB203580, BIRB796, and
staurosporine for the indicated kinase are given (1).
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